Ligand validation:6WI2

8Q1: S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate

8Q1 is a Ligand Of Interest in 6WI2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6WI2_8Q1_C_301	79%	14%	0.091	0.942	2.19	1.68	6	7	0	0	97%	0.9714
6W1D_8Q1_C_301	89%	14%	0.087	0.967	2.03	1.84	6	7	0	0	100%	0.9714
8TVT_8Q1_C_301	87%	22%	0.08	0.953	1.78	1.47	4	6	0	0	100%	0.9714
6WIH_8Q1_C_301	78%	14%	0.103	0.946	2.18	1.72	7	7	0	0	100%	0.9714
5WKP_8Q1_G_301	30%	18%	0.276	0.943	1.77	1.79	6	7	1	0	100%	0.9714
5WGB_8Q1_C_301	30%	18%	0.227	0.889	1.86	1.71	6	5	0	0	100%	0.9714
6ODD_8Q1_A_301	58%	77%	0.151	0.931	0.37	0.54	-	-	0	0	100%	0.9714

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.